Atorvastatin Calcium Patent Expiration

Atorvastatin Calcium is used for reducing LDL-C levels in patients with homozygous familial hypercholesterolemia. It was first introduced by Upjohn Manufacturing Ireland Unltd in its drug Lipitor on Dec 17, 1996. Another drug containing Atorvastatin Calcium is Atorvaliq. 33 different companies have introduced drugs containing Atorvastatin Calcium.


Atorvastatin Calcium Patents

Given below is the list of patents protecting Atorvastatin Calcium, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Atorvaliq US11369567 Aqueous suspension suitable for oral administration Jun 07, 2037 Cmp Dev Llc
Atorvaliq US11654106 Aqueous suspension suitable for oral administration Jun 07, 2037 Cmp Dev Llc
Atorvaliq US11925704 Aqueous suspension suitable for oral administration Jun 07, 2037 Cmp Dev Llc
Atorvaliq US12168069 Aqueous suspension suitable for oral administration Jun 07, 2037 Cmp Dev Llc
Lipitor US5969156

(Pediatric)

Crystalline [R- (R*,R*)]-2-(4-Dfluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)- 3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin) Jan 08, 2017

(Expired)

Upjohn
Lipitor US5969156 Crystalline [R- (R*,R*)]-2-(4-Dfluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)- 3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin) Jul 08, 2016

(Expired)

Upjohn
Lipitor US5686104

(Pediatric)

Stable oral CI-981 formulation and process of preparing same May 11, 2015

(Expired)

Upjohn
Lipitor US5686104 Stable oral CI-981 formulation and process of preparing same Nov 11, 2014

(Expired)

Upjohn
Lipitor US6126971

(Pediatric)

Stable oral CI-981 formulation and process for preparing same Jul 19, 2013

(Expired)

Upjohn
Lipitor US6126971 Stable oral CI-981 formulation and process for preparing same Jan 19, 2013

(Expired)

Upjohn



Atorvastatin Calcium's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Atorvastatin Calcium Generic API Manufacturers

Several generic applications have been filed for Atorvastatin Calcium. The first generic version for Atorvastatin Calcium was by Sun Pharmaceutical Industries Ltd and was approved on Nov 30, 2011. And the latest generic version is by Macleods Pharmaceuticals Ltd and was approved on Jun 3, 2024.

Given below is the list of companies who have filed for Atorvastatin Calcium generic, along with the locations of their manufacturing plants worldwide.